Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
This study is seeking to understand if a drug called Metformin can be used to improve thinking skills and promote white matter growth in children that have been previously treated for medulloblastoma.
Understanding how young people recover from concussion.
The BEST Trial aims to determine whether treatment of bone and joint infections in children with oral antibiotics alone is just as effective as treatment with intravenous antibiotics followed by an oral antibiotic course.
The Children’s Cancer Centre (CCC) Biobank is a valuable collection of biological samples such as tissue collected during surgery, blood and bone marrow.
The Childhood to Adolescence Transition Study (CATS) is a unique longitudinal study following 1,200 Melbourne students from childhood through adolescence and into adulthood in metropolitan Melbourne. The study began in 2012 and recruited over 1,200 children from grade three (eight to nine years of
CardioRegen is a research centre focused on improving the lives of patients with childhood heart disease (CHD). Our team of researchers and clinicians use genomics and stem cell medicine to understand the causes of CHD and to aid the discovery of new treatments.
Promoting cardioprotection in stem cell models of cardiotoxic heart damage from cancer patients. ACOR is a world's first paediatric and young adult prospective cardio-oncology registry designed to capture the clinical, epidemiological and pharmaceutical data from every Australian child and young
The 2000 Stories: Victorian Adolescent Health Cohort Study (VAHCS) is a landmark longitudinal study spanning almost 30 years. The project began in 1992 with around 2000 Year 9 students (14-15 years of age). They completed 6 assessments during school (from Years 9 – 12), three interviews in young
Researchers have discovered the blood clotting and immune protein pathways that are activated in severe cases of COVID-19 in children, paving the way for earlier diagnosis and more targeted treatments. The study led by the Murdoch Children's Research Institute (MCRI) and the University of
To develop a framework for the effective and ethical implementation of paediatric genomic sequencing, particularly rapid genomic sequencing of critically ill infants, in the Australian healthcare system.
Page 130 of 208
